ABOVE EXTREME MEN MOVEMENT 72 HOURS 19 mg/90g Aerosol, Spray, 90 g — NDC 73306-1156-01 package photo

ABOVE EXTREME MEN MOVEMENT 72 HOURS 19 mg/90g Aerosol, Spray, 90 g

by BASTON INDUSTRIA DE AEROSSOIS LTDA · 90 g in 1 BOTTLE, SPRAY (73306-1156-1)
NDC 73306-1156-01
🏷️ FDA NDC (as labeled) 73306-1156-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 73306-1156-1
Product NDC 73306-1156
11-digit billing NDC 73306115601
UNII UCN889409V
UPC 7899674039569
Application # M019
SPL Set ID fe8f7ad4-2a5a-ae30-e053-6394a90acb98
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-06-20
Route TOPICAL
Dosage form AEROSOL, SPRAY
Substance ALUMINUM SESQUICHLOROHYDRATE
Why two NDCs? The FDA registers this code as 73306-1156-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 73306-1156-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerBASTON INDUSTRIA DE AEROSSOIS LTDA
FDA applicationM019 (OTC MONOGRAPH DRUG)
Labeler code73306
First marketedJun 2023
Product typeHuman Otc Drug
Portfolio43 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter spray antiperspirant marketed for men. It contains aluminum sesquichlorohydrate, an astringent salt that is typically used in antiperspirant products to reduce underarm perspiration. The product is applied topically as an aerosol spray and is governed by the FDA's over-the-counter monograph rules for antiperspirants rather than reviewed as an individual drug application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII BXR49TP611
    Isobutane is a liquefied gas used as a propellant in aerosol inhalers and sprays. It helps push the medicine out of the container so you can breathe or spray it as directed.

1 inactive ingredient listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Above Extreme Men Movement 72 Hours 19 mg/90gthis 73306-1156-01 BASTON 90 g FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Jun 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
73306-1156-01 You're viewing this 90 g in 1 BOTTLE, SPRAY (73306-1156-1) 2023-06-20 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 73306-1156-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 73306-1156-01, written without dashes as 73306115601. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 73306-1156-01, the first segment (73306) is the labeler code FDA assigned to BASTON INDUSTRIA DE AEROSSOIS LTDA; the middle segment (1156) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by BASTON INDUSTRIA DE AEROSSOIS LTDA. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
BASTON INDUSTRIA DE AEROSSOIS LTDA is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 36 words

Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application

Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application

⏱️ Dosage and Administration 18 words

Shake the container well and apply to the underarms approximately 15cm away. Protect the eyes during the application

⚠️ Warnings and Cautions 169 words

FLAMMABLE. DO NOT USE NEAR HEAT, FLAME OR WHILE SMOKING. CAN CAUSE SERIOUS INJURY OR DEATH.

KEEP AWAY FROM FACE AND MOUTH TO AVOID BREATHING IN. AVOID SPRAYING IN EYES. CONTENTS UNDER PRESSURE.

DO NOT PUNCTURE OR INCINERATE. DO NOT EXPOSE TO HEAT, SUNLIGHT OR STORE AT TEMPERATURES ABOVE 120°F/50°C OR IN ENCLOSED PLACES THAT COULD OVERHEAT. DO NOT USE ON BROKEN SKIN.

STOP USE IF RASH OR IRRITATION OCCURS. GET MEDICAL ATTENTION IMMEDIATELY. ASK A DOCTOR BEFORE USING IF YOU HAVE KIDNEY DISEASE.

KEEP OUT OF REACH OF CHILDREN AND ANIMALS. USE ONLY AS DIRECTED. INTENTIONAL MISUSE BY DELIBERATELY CONCENTRATING AND INHALING THE CONTENTS CAN BE HARMFUL OR FATAL.

AVOID THE INHALATION OF THE PRODUCT. IN CASE OF CONTACT WITH EYES, RINSE WITH PLENTY OF WATER. IF SWALLOWED, DO NOT INDUCE VOMITING; CONSULT YOUR HEALTHCARE PROVIDER IMMEDIATELY.

DO NOT LEAVE THE AEROSOL CONTAINER IN A VEHICLE. RISK OF LEAKAGE AND EXPLOSION. CONTAINER MATERIAL: STEEL.

BATCH AND EXPIRATION ON THE BOTTOM OF THE CONTAINER. HELP STOP INHALATION ABUSE: WWW.INHALANT.ORG

⚠️ Warnings 169 words

FLAMMABLE. DO NOT USE NEAR HEAT, FLAME OR WHILE SMOKING. CAN CAUSE SERIOUS INJURY OR DEATH.

KEEP AWAY FROM FACE AND MOUTH TO AVOID BREATHING IN. AVOID SPRAYING IN EYES. CONTENTS UNDER PRESSURE.

DO NOT PUNCTURE OR INCINERATE. DO NOT EXPOSE TO HEAT, SUNLIGHT OR STORE AT TEMPERATURES ABOVE 120°F/50°C OR IN ENCLOSED PLACES THAT COULD OVERHEAT. DO NOT USE ON BROKEN SKIN.

STOP USE IF RASH OR IRRITATION OCCURS. GET MEDICAL ATTENTION IMMEDIATELY. ASK A DOCTOR BEFORE USING IF YOU HAVE KIDNEY DISEASE.

KEEP OUT OF REACH OF CHILDREN AND ANIMALS. USE ONLY AS DIRECTED. INTENTIONAL MISUSE BY DELIBERATELY CONCENTRATING AND INHALING THE CONTENTS CAN BE HARMFUL OR FATAL.

AVOID THE INHALATION OF THE PRODUCT. IN CASE OF CONTACT WITH EYES, RINSE WITH PLENTY OF WATER. IF SWALLOWED, DO NOT INDUCE VOMITING; CONSULT YOUR HEALTHCARE PROVIDER IMMEDIATELY.

DO NOT LEAVE THE AEROSOL CONTAINER IN A VEHICLE. RISK OF LEAKAGE AND EXPLOSION. CONTAINER MATERIAL: STEEL.

BATCH AND EXPIRATION ON THE BOTTOM OF THE CONTAINER. HELP STOP INHALATION ABUSE: WWW.INHALANT.ORG

🧪 Active Ingredient 2 words

ALUMINUM SESQUICHOLOHYDRATE

🧪 Inactive Ingredients 151 words

BUTANE (BUTANO) PROPANE (PROPANO) ISOBUTANE (ISOBUTANO) ISOPROPYL MYRISTATE (MIRISTATO DE ISOPROPILA) ISODODECANE (ISODODECANO) AQUA (ÁGUA) PPG-14 BUTYL ETHER (ÉTER BUTÍLICO PPG-14) PARFUM (PERFUME) QUATERNIUM-18 HECTORITE (QUATÉRNIO-18 HECTORITA) 2-METHYL 5-CYCLOHEXYLPENTANOL (2-METIL 5-CICLOEXILPENTANOL) PROPYLENE CARBONATE (CARBONATO DE PROPILENO) TOCOPHERYL ACETATE (ACETATO DE DEXTROALFATOCOFEROL) GOSSYPIUM HERBACEUM SEED OIL (ÓLEO DA SEMENTE DE ALGODOEIRO) BUTYROSPERMUM PARKII BUTTER (MANTEIGA DE KARITÉ) MACADAMIA TERNIFOLIA SEED OIL (ÓLEO DA SEMENTE DE MACADÂMIA) COCOS NUCIFERA FRUIT EXTRACT (EXTRATO DO FRUTO DE COQUEIRO) CHAMOMILLA RECUTITA FLOWER EXTRACT (EXTRATO DA FLOR DE CAMOMILA) ALOE BARBADENSIS LEAF EXTRACT (EXTRATO DA FOLHA DE ALOE VERA) CAMELLIA SINENSIS LEAF EXTRACT (EXTRATO DA FOLHA DE CHÁ-DA-ÍNDIA) CINNAMOMUM ZEYLANICUM BARK EXTRACT (EXTRATO DA CASCA DE CANELEIRA) ACORUS CALAMUS ROOT EXTRACT (EXTRATO DA RAIZ DE CÁLAMO-AROMÁTICO) COMMIPHORA MYRRHA RESIN EXTRACT (EXTRATO DA RESINA DE MIRRA) OLEA EUROPAEA FRUIT OIL (ÓLEO DE OLIVA) ARGANIA SPINOSA KERNEL OIL (ÓLEO DE ARGAN) LECITHIN (LECITINA) POLYGLYCERYL-3 DIISOSTEARATE (DIISOESTEARATO DE POLIGLICERILA-3) &nb

🎯 Purpose 1 words

ANTIPERSPIRANT

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.